2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
140 - 205
MetadataShow full item record
AuthorsMach, F; Baigent, C; Catapano, AL; Koskina, KC; Casula, M; Badimon, L; Chapman, MJ; De Backer, GG; Delgado, V; Ference, BA
- NIHR Advanced Imaging 
Showing items related by title, author, creator and subject.
Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes Fredrikson, GN; Anand, DV; Hopkins, D; Corder, R; Alm, R; Bengtsson, E; Shah, PK; Lahiri, A; Nilsson, J (2009-07)
Timpson, NJ; Walter, K; Min, JL; Tachmazidou, I; Malerba, G; Shin, S-Y; Chen, L; Futema, M; Southam, L; Iotchkova, V (2014-09-16)The analysis of rich catalogues of genetic variation from population-based sequencing provides an opportunity to screen for functional effects. Here we report a rare variant in APOC3 (rs138326449-A, minor allele frequency ...
Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36 Love-Gregory, L; Kraja, AT; Allum, F; Aslibekyan, S; Hedman, AK; Duan, Y; Borecki, IB; Arnett, DK; McCarthy, MI; Deloukas, P (2016-12)